Şehnaz Alp
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility 11
- SARS-CoV-2 and COVID-19 Research 3
-
- Fungal Infections and Studies 10
- Pneumonia and Respiratory Infections 3
- Nail Diseases and Treatments 3
-
- Infectious Diseases and Mycology 3
-
- Vector-borne infectious diseases 2
-
- Mosquito-borne diseases and control 2
Şehnaz Alp
29 papers receiving 307 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 220
- Applied Microbiology and Biotechnology 10
- Epidemiology 153
- Clinical Biochemistry 28
- Microbiology 2
Countries citing papers authored by Şehnaz Alp
This map shows the geographic impact of Şehnaz Alp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şehnaz Alp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şehnaz Alp more than expected).
Fields of papers citing papers by Şehnaz Alp
This network shows the impact of papers produced by Şehnaz Alp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şehnaz Alp. The network helps show where Şehnaz Alp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Şehnaz Alp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 6 | |
| 3 | 2021 | 5 | |
| 4 | Novel coronavirus (SARS-CoV-2) pandemic: Overview and current status | 2020 | 4 |
| 5 | 2020 | 16 | |
| 6 | 2020 | 11 | |
| 7 | 2019 | 2 | |
| 8 | 2018 | 1 | |
| 9 | 2016 | 15 | |
| 10 | 2015 | 28 | |
| 11 | 2013 | 11 | |
| 12 | 2013 | 22 | |
| 13 | [Comparison of culture and real-time PCR methods in the detection of Streptococcus pneumoniae and Haemophilus influenzae in acute otitis media effusion specimens]. | 2012 | 3 |
| 14 | 2009 | 13 | |
| 15 | 2009 | 10 | |
| 16 | 2009 | 10 | |
| 17 | [Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods]. | 2009 | 8 |
| 18 | 2008 | 32 | |
| 19 | [Determination of in vitro susceptibility of Candida species to amphotericin B by E-test and previously proposed MIC breakpoints on two different media]. | 2008 | 1 |
| 20 | 2008 | 53 |
About Şehnaz Alp
Şehnaz Alp is a scholar working on Infectious Diseases, Microbiology and Epidemiology, having authored 29 papers that have together received 320 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (10 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Pneumonia and Respiratory Infections (3 papers), Nail Diseases and Treatments (3 papers), Infectious Diseases and Mycology (3 papers), Vector-borne infectious diseases (2 papers) and Mosquito-borne diseases and control (2 papers). The work is most often cited by research in Infectious Diseases (220 citations), Applied Microbiology and Biotechnology (10 citations) and Epidemiology (153 citations). Şehnaz Alp has collaborated with scholars based in Türkiye, Cyprus and Czechia. Frequent co-authors include Sevtap Arıkan, Murat Akova, Gülşen Hasçelik, Banu Sancak, Paul M. McNicholas, Sevtap Arıkan-Akdağlı, Serhat Ünal, Dolunay Gülmez, Ahmet Çağkan İnkaya and Ömrüm Uzun. Their work appears in journals such as Mycoses, Clinical Microbiology and Infection, Zoonoses and Public Health, Therapeutic Advances in Infectious Disease and Flora.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.